Trader Note — 9852 total
SRZN heads into the post-print session carrying a rare contradiction: fresh institutional conviction, visible insider exits, and a Q1 EPS miss that dwarfs any prior consensus estimate. The earnings release, filed…
RXST enters the week following its Q1 earnings release with a notable shift in short positioning — shorts that built aggressively through late April are now unwinding, even as the stock trades at just $7.26. Short…
Robinhood Markets dropped 15% after its April 28 earnings release — yet the data reveals a stock where short sellers are rebuilding gradually, not aggressively, and where options positioning is unusually calm. The…
AUR just delivered the week that bulls had been waiting for — and it arrived with back-to-back newsflow catalysts. The stock closed at $6.53 on May 5, up 32% on the week and 57% over the past month, driven by an…
Sight Sciences just delivered a split verdict — Q1 sales beat but earnings missed, and then management raised the full-year bar anyway. That combination is the heart of this week's setup heading into the post-earnings…
Sera Prognostics enters the post-earnings window in a fragile position. Q1 revenue missed sharply, the stock has lost 5% on the week, and short interest has quietly rebuilt itself to levels not seen since early…
Zevia PBC heads into Thursday's post-close session on an unusual footing: the company just delivered a Q1 sales beat and raised full-year guidance, yet the stock dropped 5% on Tuesday to $1.25 — making the reaction to…
TKNO just delivered its strongest week in months. The stock gained 14% to close at $3.74, fuelled by a Q1 earnings beat that landed after the close on May 6 — and the gap between what bulls and bears are reading into…
TASK heads into the post-earnings tape with the most significant short-covering story it has seen in months. The clearest signal is the dramatic unwind in short positioning. Short interest peaked at nearly 17.6% of…
Lyell Immunopharma reported its Q1 2026 results after the close on May 6 — EPS of -$1.10 beat the -$2.19 consensus estimate, though revenue of $2,000 came in below the $4,400 estimate. The stock enters the week down 4%…
Tenaya Therapeutics reported Q1 2026 results just after Wednesday's close. The headline number landed on both sides of the ledger — EPS of -$0.09 missed the -$0.06 estimate, but revenue of $25 million crushed the $10…
HNST enters its Q1 2026 results — due after the bell tomorrow, May 7 — with short sellers in full retreat and the stock up 22% in a month, a notably charged setup for a sub-$4 name in personal care. The most compelling…
Context Therapeutics enters its Q1 2026 earnings release with short sellers having already made a decisive exit — and Q1 EPS just printed a beat, coming in at -$0.09 versus the -$0.12 estimate. Short interest has…
AGL heads into the post-earnings session having tripled from the canvas — and the Street's response is already turning cooler. The stock closed Tuesday at $26.74, up 149% over the past month. That recovery traces…
DoubleVerify Holdings is walking into its May 21 Q1 results with a split personality in positioning: short sellers adding exposure at the fastest pace in months, while options traders have swung to their most bullish…
PureCycle Technologies just beat Q1 estimates — and the shorts are barely flinching. The stock closed at $7.65 on Tuesday, up 8% on the week and 41% over the past month. Q1 EPS came in at -$0.21, beating the -$0.25…
Aeva Technologies heads into this week with a striking contrast: one of the most heavily shorted small-cap names in the sensor space, yet options traders are the least bearish they have been all year. The short…
ACV Auctions just reported its cleanest quarter yet — and the market responded by pushing the stock up 8% on the week before the earnings print even landed. The Q1 numbers, released after the close on May 6, came in…
Stem, Inc. just reported Q1 results into one of the most charged short-positioning setups it has seen all year. Q1 delivered a classic beat-miss split. EPS came in at -$2.22, better than the -$2.30 consensus. Revenue…
APA Corporation enters its May 7 Q1 results sitting in an unusual position: short sellers have been stepping back sharply, options traders are leaning constructive, and the Street — while not enthusiastic — has been…
